Bill Gates AI Drug Discovery Shouldn't need to say much more I think bottom is in GRI 2022
Gill Bates Innit Do wot u want tho GRI 2022 NOT TARDING ADVICE
Either is fine by me Not tarding advice GRI 2022
AI drug discovery stonk Early stage Bill Gates Apparently a lot of big pharma already use it Seems to me a better play than vaccine stonks RN which is crowded Looks bearish Basically on final support else back to ground 0 (two horizontal lines) NOT FINANCIAL ADVICE
Looking for a pattern repeat on the channel. Break of purple line would be confirmation
As a trade, it's probably safer to wait for SDGR to break through $78 and 79, but I took a half position this week. My conjecture is that the S1 pivot will provide stronger support, than the resistance to be faced at R1. More importantly, I believe the broader market trend (bullish, with momentum) will help advance SDGR. Looking for low to mid 80's target price...
They have negative EPS and not acceptable growth and income (~100M$) for a 4.5B $ company, soon the earnings will arrive and my guess is that price will drop because some investors will not like the numbers. But then the technical rational players will leave the arena and the irrational hype will start Results can be found "improving" for some :) and then...
On the Daily chart looks like a rising wedge, looking for a rise before earnings!
Possible end of this 1-2 1-2. Price is now at 0.618% with support of ema 150 on the daily tf. If confirmed, target is $225 for this sub-wave 3
I believe this is a beginning of a new era not the end! Not even close to the end! These stocks just crossed below their 200 EMA, and made serious reversal patterns! They will go down more with time! Reevaluate your stop loss would save you a lot !
Entry price: 90.75 Fundamentals : - Sector: Medical - Research - EPS % Chg (Last Qtr): 128% - EPS % Chg (Previous Qtr): 34% - 3 Year EPS Growth Rate: 0% - EPS Est % Chg (Current Yr): 0% - Sales % Chg (Last Qtr): 29% - Sales % Chg (Previous Qtr): 21% - 3-Year Sales Growth Rate: 23% - Annual Pre -Tax Margin: -30.4%
Target price for SDGR cup and handle is $140. Good way to go from here. I've picked up a decent amount. Wish I could grab more but still waiting for AAPL cup and handle to run up.
Earnings 3-4. Large effective Volume on Friday. No rising wedges noted in yearly chart. Up quite a bit today so perhaps wait for a good entry. This gapped up at open and I am not sure why? Perhaps smart money trying to skip over resistance...not sure but it is now over the prior high. Not a recommendation.. Schrödinger, Inc. provides computational...
We are in the midst of a biotech boom. SDGR sits to profit greatly, selling cost/time saving software. They sell drug/material discovery software to biotechs and pharma companies. They also fully or jointly own some early stage/preclinical drug programs as well. Here are the investment highlights I believe are key. 1- Their physics based software makes new...
Physics driven AI for Drug Discovery? Say less.